Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Roche renews commitment to R&D of two AD drugs
Roche renews commitment to R&D of two AD drugs
Roche renews commitment to R&D of two AD drugs
Submitted by
admin
on July 24, 2015 - 8:14am
Source:
BioPharma Dive
News Tags:
Roche
R&D
gantenerumab
crenezumab
Alzheimer's disease
Headline:
Roche renews commitment to R&D of two AD drugs
Do Not Allow Advertisers to Use My Personal information
